Gilada Finance & Investments has closed its trading window for equity shares effective July 1, 2026, to prevent insider trading ahead of its quarterly financial results. The window will remain shut until 48 hours after the company declares its unaudited financial results for the quarter ending June 30, 2026. This measure ensures compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct for monitoring trades by insiders.

During this closure period, all designated persons, including board members, connected persons, and their immediate relatives, are strictly prohibited from dealing in the company's securities. The restriction applies to all equity shares of Gilada Finance & Investments Limited. The company has stated that the specific date for the Board of Directors' meeting to approve the unaudited financial results for Q1FY27 will be communicated in due course.

The trading window closure is a standard regulatory procedure implemented by listed companies to ensure that no insider trading takes place while material non-public information, such as financial results, is pending. The intimation was formally submitted to the BSE Limited on June 23, 2026, by Chaitra G S, Company Secretary and Compliance Officer.

Gilada Finance and Investments Limited approved a strategic joint venture with Harley of London India to collaborate in healthcare, wellness, and financial services. The board also approved the allotment of Non-Convertible Debentures (NCDs) worth ₹5,00,000 on a private placement basis to raise capital. These decisions were taken during a board meeting held on June 19, 2026.

The board authorized Managing Director Mr. Raigopal Gilada to finalize and execute the Joint Venture Agreement with Harley of London India, sponsored by the Delamore & Owl Group. The partnership aims to leverage the HOLNESS ecosystem for business initiatives across various sectors.

The company allotted 5 NCDs of face value ₹1,00,000 each at a coupon rate of 12.25% per annum. The debt instruments have a tenure of 2 years and are non-cumulative in nature.

Additionally, the board appointed Anand Boob & Associates as the internal auditor for the financial year 2026-27. The disclosure was submitted to BSE Limited under Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.